Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood

Mucosal Immunology

Volumn 10, Issue 1, 2017, Pages 117-127

  Yan, F ^a   Liu, L ^a   Cao, H ^b   Moore, D J ^a   Washington, M K ^a   Wang, B ^b   Peek, R M ^a   Acra, S A ^a   Polk, D B ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; DEXTRAN SULFATE; PROBIOTIC AGENT;

ADULT; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENTERITIS; FECES ANALYSIS; FEMALE; GROWTH; HOST; IMMUNOGLOBULIN PRODUCTION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS GG; MATURATION; MOUSE; NONHUMAN; SPECIES DIVERSITY; SPECIES RICHNESS; TIGHT JUNCTION; WEIGHT GAIN; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; HUMAN; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; NEWBORN; PATHOLOGY; PHYSIOLOGY; PREGNANCY; SYMBIOSIS;

ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; CELLS, CULTURED; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOGLOBULIN A; INTESTINAL MUCOSA; INTESTINES; LACTOBACILLUS RHAMNOSUS; MICE; MICE, INBRED C57BL; PREGNANCY; PROBIOTICS; SYMBIOSIS; TIGHT JUNCTIONS;

EID: 85011022848     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.43     Document Type: Article

References (63)

1. Aagaard, K., Ma, J., Antony, K.M., Ganu, R., Petrosino, J. &Versalovic, J. The placenta harbors a unique microbiome. Sci. Transl. Med. 6, 237ra265 (2014).
2. Dominguez-Bello, M.G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 107, 11971-11975 (2010).
3. Nicholson, J.K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262-1267 (2012).
4. Walker, W.A. Initial intestinal colonization in the human infant and immune homeostasis. Ann. Nutr. Metab. 63, 8-15 (2013).
5. Haberman, Y. et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J. Clin. Invest. 124, 3617-3633 (2014).
6. Hansen, R. et al. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am. J. Gastroenterol. 107, 1913-1922 (2012).
7. Michail, S. et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm. Bowel. Dis. 18, 1799-1808 (2012).
8. Raymond, F. et al. The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J. 10, 707-720 (2016).
9. Kronman, M.P., Zaoutis, T.E., Haynes, K., Feng, R. &Coffin, S.E. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130, e794-e803 (2012).
10. Berg, R.D. The indigenous gastrointestinal microflora. Trends Microbiol. 4, 430-435 (1996).
11. Hooper, L.V., Wong,M.H., Thelin, A., Hansson, L., Falk, P.G. &Gordon, J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884 (2001).
12. Cox, L.M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721 (2014).
13. Preidis, G.A., Hill, C., Guerrant, R.L., Ramakrishna, B.S., Tannock, G.W. &Versalovic, J. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 140, 8-14 (2011).
14. Guandalini, S. Probiotics for prevention and treatment of diarrhea. J. Clin. Gastroenterol. 45, S149-S153 (2011).
15. Sanders, M.E. et al. An update on the use and investigation of probiotics in health and disease. Gut 62, 787-796 (2013).
16. Patel, R.M., Myers, L.S., Kurundkar, A.R., Maheshwari, A., Nusrat, A. &Lin, P.W. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol. 180, 626-635 (2012).
17. Preidis, G.A. et al. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J. 26, 1960-1969 (2012).
18. Becker, S. et al. Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PLoS One 8, e55620 (2013).
19. Forestier, C., De Champs, C., Vatoux, C. &Joly, B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 152, 167-173 (2001).
20. Dotterud, C.K. et al. Does maternal perinatal probiotic supplementation alter the intestinal microbiota of mother and child? J. Pediatr. Gastroenterol. Nutr. 61, 200-207 (2015).
21. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. &Isolauri, E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079 (2001).
22. Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H. &Isolauri, E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869-1871 (2003).
23. Kalliomaki, M., Salminen, S., Poussa, T. &Isolauri, E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119, 1019-1021 (2007).
24. Scalabrin, D.M., Johnston, W.H., Hoffman, D.R., P'Pool, V.L., Harris, C.L. &Mitmesser, S.H. Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial. Clin. Pediatr. 48, 734-744 (2009).
25. Doron, S., Snydman, D.R. &Gorbach, S.L. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol. Clin. North Am. 34, 483-498 (2005).
26. Wang, L. et al. Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GGderived protein. J. Biol. Chem. 289, 20234-20244 (2014).
27. Yan, F. et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 121, 2242-2253 (2011).
28. Yan, F., Cao, H., Cover, T.L., Whitehead, R.,Washington, M.K. &Polk, D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575 (2007).
29. Hansen, C.H. et al. Patterns of early gut colonization shape future immune responses of the host. PLoS One 7, e34043 (2012).
30. Guan, L.L., Hagen, K.E., Tannock, G.W., Korver, D.R., Fasenko, G.M. &Allison, G.E. Detection and identification of Lactobacillus species in crops of broilers of different ages by using PCR-denaturing gradient gel electrophoresis and amplified ribosomal DNA restriction analysis. Appl. Environ. Microbiol. 69, 6750-6757 (2003).
31. Walter, J., Heng, N.C., Hammes, W.P., Loach, D.M., Tannock, G.W. &Hertel, C. Identification of Lactobacillus reuteri genes specifically induced in the mouse gastrointestinal tract. Appl. Environ. Microbiol. 69, 2044-2051 (2003).
32. Ahlroos, T. &Tynkkynen, S. Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR. J. Appl. Microbiol. 106, 506-514 (2009).
33. Agarwal, R. et al. Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J. Pediatr. Gastroenterol. Nutr. 36, 397-402 (2003).
34. Seth, A., Yan, F., Polk, D.B. &Rao, R.K. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC-and MAP kinasedependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1060-G1069 (2008).
35. Yoda, K., Miyazawa, K., Hosoda, M., Hiramatsu, M., Yan, F. &He, F. Lactobacillus GG-fermented milk prevents DSS-induced colitis and regulates intestinal epithelial homeostasis through activation of epidermal growth factor receptor. Eur. J. Nutr. 53, 105-115 (2014).
36. Pabst, O. New concepts in the generation and functions of IgA. Nat. Rev. Immunol. 12, 821-832 (2012).
37. Chattha, K.S. et al. Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine. Vaccine 31, 1916-1923 (2013).
38. de Vrese, M., Rautenberg, P., Laue, C., Koopmans, M., Herremans, T. &Schrezenmeir, J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur. J. Nutr. 44, 406-413 (2005).
39. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
40. Lopez-Serrano, P., Perez-Calle, J.L., Perez-Fernandez, M.T., Fernandez-Font, J.M., Boixeda de Miguel, D. &Fernandez-Rodriguez, C.M. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand. J. Gastroenterol. 45, 1464-1471 (2010).
41. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493 (2012).
42. Egger, B., Bajaj-Elliott, M., MacDonald, T.T., Inglin, R., Eysselein, V.E. &Buchler, M.W. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62, 240-248 (2000).
43. Garside, P. Cytokines in experimental colitis. Clin. Exp. Immunol. 118, 337-339 (1999).
44. Petschow, B.W., Figueroa, R., Harris, C.L., Beck, L.B., Ziegler, E. &Goldin, B. Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants. J. Clin. Gastroenterol. 39, 786-790 (2005).
45. Round, J.L. et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977 (2011).
46. Yan, F. et al. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor. J. Biol.Chem. 288, 30742-30751 (2013).
47. Dharmani, P., Srivastava, V., Kissoon-Singh, V. &Chadee, K. Role of intestinal mucins in innate host defense mechanisms against pathogens. J. Innate Immun. 1, 123-135 (2009).
48. Martens, E.C., Roth, R., Heuser, J.E. &Gordon, J.I. Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J. Biol. Chem. 284, 18445-18457 (2009).
49. Backhed, F. et al. Dynamics and stabilization of the human gutmicrobiome during the first year of life. Cell Host Microbe 17, 690-703 (2015).
50. Martin, R. et al. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res. Microbiol. 158, 31-37 (2007).
51. Martin, R. et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl. Environ. Microbiol. 75, 965-969 (2009).
52. Rogier, E.W. et al. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc. Natl. Acad. Sci. USA 111, 3074-3079 (2014).
53. Fransen, F. et al. BALB/c and C57BL/6 mice differ in polyreactive IgA abundance, which impacts the generation of antigen-specific IgA and microbiota diversity. Immunity 43, 527-540 (2015).
54. Endo, A., Prtty, A., Kalliomki, M., Isolauri, E. &Salminen, S. Long-term monitoring of the human intestinal microbiota from the 2nd week to 13 years of age. Anaerobe 28, 149-156 (2014).
55. Spor, A., Koren, O. &Ley, R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279-290 (2011).
56. Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105, 16731-16736 (2008).
57. Kanai, T., Mikami, Y. &Hayashi, A. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease. J. Gastroenterol. 50, 928-935 (2015).
58. He, B. et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26, 812-826 (2007).
59. Xu,W. et al. Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat. Immunol. 8, 294-303 (2007).
60. Luoto, R., Kalliomaki, M., Laitinen, K. &Isolauri, E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int. J. Obes. 34, 1531-1537 (2010).
61. Yan, F. &Polk, D.B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277, 50959-50965 (2002).
62. Caporaso, J.G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
63. Kennedy, R.J., Hoper, M., Deodhar, K., Erwin, P.J., Kirk, S.J. &Gardiner, K.R. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br. J. Surg. 87, 1346-1351 (2000).